^
BIOMARKER:

BCL2 D103Y

i
Other names: BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Entrez ID:
BCL2 D103Y
CLL
venetoclax + obinutuzumab
Resistant: C3 – Early Trials
BCL2 D103Y
CLL
venetoclax + rituximab
Resistant: C3 – Early Trials